Literature DB >> 19832839

Recent insights into PDGF-induced gliomagenesis.

Filippo Calzolari1, Paolo Malatesta.   

Abstract

Gliomas are aggressive and almost incurable glial brain tumors which frequently display abnormal platelet-derived growth factor (PDGF) signaling. Evidence gained from studies on several in vivo animal models has firmly established a causal connection between aberrant PDGF signaling and the formation of some gliomas. However, only recently has significant knowledge been gained regarding crucial issues such as the glioma cell of origin and the relationship between the transforming stimulus and the cellular characteristics of the resulting tumor. Based on recent evidence, we propose that PDGF can bias cell-fate decisions, driving the acquisition of cell type-specific features by the progeny of multipotent neural progenitors, thus determining the shape and direction of the transformation path. Furthermore, recent data about the cellular mechanisms of PDGF-driven glioma progression and maintenance indicate that PDGF may be required, unexpectedly, to override cell contact inhibition and promote glioma cell infiltration rather than to stimulate cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19832839     DOI: 10.1111/j.1750-3639.2009.00335.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  25 in total

1.  Scram1 is a modifier of spinal cord resistance for astrocytoma on mouse Chr 5.

Authors:  Jessica Amlin-Van Schaick; Sungjin Kim; Karl W Broman; Karlyne M Reilly
Journal:  Mamm Genome       Date:  2011-12-08       Impact factor: 2.957

2.  PDGF-B exploits stromal EPO.

Authors:  Lisa M McGinnis; Calvin J Kuo
Journal:  Nat Med       Date:  2012-01-06       Impact factor: 53.440

Review 3.  Insights into molecular therapy of glioma: current challenges and next generation blueprint.

Authors:  Y Rajesh; Ipsita Pal; Payel Banik; Sandipan Chakraborty; Sachin A Borkar; Goutam Dey; Ahona Mukherjee; Mahitosh Mandal
Journal:  Acta Pharmacol Sin       Date:  2017-03-20       Impact factor: 6.150

4.  Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma.

Authors:  David A Reardon; Annick Desjardins; James J Vredenburgh; James E Herndon; April Coan; Sridharan Gururangan; Katherine B Peters; Roger McLendon; Sith Sathornsumetee; Jeremy N Rich; Eric S Lipp; Dorothea Janney; Henry S Friedman
Journal:  Cancer       Date:  2012-02-27       Impact factor: 6.860

Review 5.  Complex oncogenic signaling networks regulate brain tumor-initiating cells and their progenies: pivotal roles of wild-type EGFR, EGFRvIII mutant and hedgehog cascades and novel multitargeted therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Brain Pathol       Date:  2011-07-07       Impact factor: 6.508

Review 6.  Review: insights gained from modelling high-grade glioma in the mouse.

Authors:  S L Rankin; G Zhu; S J Baker
Journal:  Neuropathol Appl Neurobiol       Date:  2012-06       Impact factor: 8.090

7.  Platelet-derived growth factor beta is a potent inflammatory driver in paediatric high-grade glioma.

Authors:  James L Ross; Zhihong Chen; Cameron J Herting; Yura Grabovska; Frank Szulzewsky; Montserrat Puigdelloses; Lenore Monterroza; Jeffrey Switchenko; Nitin R Wadhwani; Patrick J Cimino; Alan Mackay; Chris Jones; Renee D Read; Tobey J MacDonald; Matthew Schniederjan; Oren J Becher; Dolores Hambardzumyan
Journal:  Brain       Date:  2021-02-12       Impact factor: 13.501

8.  Crosstalk between glioma-initiating cells and endothelial cells drives tumor progression.

Authors:  Hye-Min Jeon; Sung-Hak Kim; Xun Jin; Jong Bae Park; Se Hoon Kim; Kaushal Joshi; Ichiro Nakano; Hyunggee Kim
Journal:  Cancer Res       Date:  2014-06-24       Impact factor: 12.701

9.  ZIP4 is a novel molecular marker for glioma.

Authors:  Yi Lin; Yong Chen; Yongzhi Wang; Jingxuan Yang; Vivian F Zhu; Yulun Liu; Xiaobo Cui; Leon Chen; Wei Yan; Tao Jiang; Georgene W Hergenroeder; Stephen A Fletcher; Jonathan M Levine; Dong H Kim; Nitin Tandon; Jay-Jiguang Zhu; Min Li
Journal:  Neuro Oncol       Date:  2013-04-17       Impact factor: 12.300

10.  PDGF-B-mediated downregulation of miR-21: new insights into PDGF signaling in glioblastoma.

Authors:  Pedro M Costa; Ana L Cardoso; Luis F Pereira de Almeida; Jeffrey N Bruce; Peter Canoll; Maria C Pedroso de Lima
Journal:  Hum Mol Genet       Date:  2012-08-24       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.